← Back to Search

Electronic Health Record Strategies for Patient Engagement

N/A
Waitlist Available
Led By Brian Smith, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will study whether adding banners, a chatbot, and direct messaging to an online patient portal will increase interest in research among portal users.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients who create a research profile
Secondary outcome measures
Number of patients who enroll in a research study

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

16Treatment groups
Experimental Treatment
Active Control
Group I: Traditional Letter OnlyExperimental Treatment1 Intervention
*A mailed letter will invite the patient to set up a research profile in their patient portal.
Group II: Traditional Letter + Direct to Patient Message + Chatbot + BannerExperimental Treatment4 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group III: Traditional Letter + Direct to Patient Message + ChatbotExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group IV: Traditional Letter + Direct to Patient Message + BannerExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group V: Traditional Letter + Direct to Patient MessageExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Group VI: Traditional Letter + Chatbot + BannerExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests. AND *Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group VII: Traditional Letter + ChatbotExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group VIII: Traditional Letter + BannerExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group IX: Direct to Patient Message OnlyExperimental Treatment1 Intervention
*An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Group X: Direct to Patient Message + Chatbot + BannerExperimental Treatment3 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XI: Direct to Patient Message + ChatbotExperimental Treatment2 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group XII: Direct to Patient Message + BannerExperimental Treatment2 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XIII: Chatbot OnlyExperimental Treatment1 Intervention
*A real-time, interactive chatbot on the patient portal will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group XIV: Chatbot + BannerExperimental Treatment2 Interventions
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about clinical trial opportunities and trials that match their interests; AND Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care will inform patients of research opportunities.
Group XV: Banner OnlyExperimental Treatment1 Intervention
*Banner-type "advertisements" will appear during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XVI: No InterventionActive Control1 Intervention
*No intervention.

Find a Location

Who is running the clinical trial?

Food and Drug Administration (FDA)FED
169 Previous Clinical Trials
604,794 Total Patients Enrolled
Yale UniversityLead Sponsor
1,830 Previous Clinical Trials
2,000,954 Total Patients Enrolled
Brian Smith, MDPrincipal InvestigatorYale School of Medicine

Media Library

Direct to Patient Message Clinical Trial Eligibility Overview. Trial Name: NCT05348603 — N/A
Patient Engagement Research Study Groups: Traditional Letter + Banner, Direct to Patient Message + Chatbot, Traditional Letter + Direct to Patient Message + Chatbot, Traditional Letter + Chatbot + Banner, Direct to Patient Message + Chatbot + Banner, Traditional Letter + Direct to Patient Message + Chatbot + Banner, No Intervention, Traditional Letter + Direct to Patient Message, Traditional Letter Only, Chatbot Only, Traditional Letter + Chatbot, Direct to Patient Message Only, Direct to Patient Message + Banner, Traditional Letter + Direct to Patient Message + Banner, Banner Only, Chatbot + Banner
Patient Engagement Clinical Trial 2023: Direct to Patient Message Highlights & Side Effects. Trial Name: NCT05348603 — N/A
Direct to Patient Message 2023 Treatment Timeline for Medical Study. Trial Name: NCT05348603 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any further participants needed for this trial?

"Indeed, the information on clinicaltrials.gov reveals that this trial is open to recruitment. It was initially posted on September 13th 2022 and was last updated on October 18th 2022. The study seeks to enrol 750 thousand patients from a single site."

Answered by AI

How many participants are being included in this research project?

"Correct. According to clinicaltrials.gov, this ongoing medical study is still seeking participants and was initially posted on September 13th 2022. This experiment requires the recruitment of 750 thousand people from a single location."

Answered by AI
~300496 spots leftby Feb 2025